Lincoln Stein lays out "The case for cloud computing in genome informatics" pretty nicely. The article describes the inflection point of sequencing technology. That is from 1990 to 2004 'base-pair/$' doubled every 19 months versus a doubling every 5 months since 2004 to present. There is no end in sight. Moving data to the ...
Despite understandably varied opinions on the US federal government, I think that most of us can agree that U.S. National Institute of Health (NIH) has done remarkable things for the world and life sciences. They are the world driver and biggest supporter of genetic research, they largely funded the $3B Human Genome Project, and ...
Following an earlier post, the ruling by the federal judge 0n the BRCA patents held by Myriad has created a firestorm of controversy in the blogs and in the popular media. Check this out!: NPR: Gene Ruling Could Have Wide Implications 60 Minutes: Gene Patents The industry blog Genetic Future has sponsored an ...
The most thoughtful folks in the health care industry acknowledge that the future will be defined by molecular (aka personalized) medicine. Without being infinitely tedious, it will be a matter of measuring your body's instructions (DNA) and your present state (RNA/proteins) and prescribing a course of treatment with the most likely positive outcome and ...
Earlier I blogged on the distinctions between Infrastructure, Platform, and Software-as-a-Service offerings. The message was that "cloud" is an overloaded word and takes many forms and has different customer value propositions. A recent commentary in GenomeWeb "Considering a Cloud? Cost isn't everything..." citing the paper "The Real Cost of a CPU Hour" ...
GenomeQuest could have targeted consumers, the largest available market for its technology. When we entered the market in 2004, the consumer wave was a distant vision, not even on the horizon. How did we survive? We targeted the smallest segment we could find: Information Scientists and Biotech Patent Lawyers. Why? My father was a old-school ...
Brad Perriello at MassDevice interviewed me and posted the article in their popular e-newsletter on the medical device industry. You can read the interview here. Brad caught me a little off guard when he asked me what I considered to be the ethical implications of individuals having access to their genomes. In a couple ...
An article by Nicholas Wade, science writer for the New York Times Disease Cause Is Pinpointed With Genome describes two research teams who have independently sequenced the entire genome of patients to find the exact genetic cause of their diseases. A fantastic research blog post at Genetic Future titled Disease hunting ...
Brilliant analytical overview of Next-Generation Sequencing machines compiled by Dan Koboldt at MassGenomics from the recent AGBT event in Marco Island. And another by Boonsri Dickinson at SmartPlanet The amazing race for the cheapest and fastest DNA machine.
Today, we launched our API’s for Sequence Data Management on the cloud. So what? GenomeQuest is now for bioinformatics and computational biologists (we call them developers for short). These are people who prefer to write code in Unix, and prefer awk, perl, and sed to Firefox, Internet Explorer, Safari, or Chrome. So why is that important? With no ...